<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458000</url>
  </required_header>
  <id_info>
    <org_study_id>ISR-2016-10770</org_study_id>
    <nct_id>NCT03458000</nct_id>
  </id_info>
  <brief_title>Capsule Endoscopy for HEmorrhage in the ER</brief_title>
  <acronym>CHEER</acronym>
  <official_title>Capsule Endoscopy for Hemorrhage in the ER</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>George Washington University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center randomized controlled trial examining the use of Video Capsule
      Endoscopy (VCE) to discharge low-moderate risk patients with suspected upper gastrointestinal
      bleeds (UGIB) from the Emergency Department (ED.) The investigators will enroll 100 subjects
      at 4 sites who present with signs of hemodynamically stable UGIBs and compare VCE risk
      assessment to an Active Control (AC) group who receive inpatient upper endoscopy (EGD).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2018</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient disposition</measure>
    <time_frame>12 months</time_frame>
    <description>Our primary goal is to determine whether ED VCE is able to discharge low risk patients for outpatient management of upper GI bleeds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of Video Capsule Endoscopy</measure>
    <time_frame>12 months</time_frame>
    <description>Our secondary objective is to estimate sensitivity and specificity of VCE compared to subsequent EGD in the detection of serious bleeding lesions in the upper gastrointestinal (GI) tract.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>Active Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Video Capsule Endoscopy will be administered during ED, but video will not be read until after inpatient EGD. Subject will have hospital admission with an EGD conducted during hospital stay.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will have Video Capsule Endoscopy read during ED length of stay, disposition will be determined using Capsule Endoscopy Risk Assessment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PillCam UGI</intervention_name>
    <description>An esophageal capsule endoscope which is designed to visualize the upper gastrointestinal tract.</description>
    <arm_group_label>Active Control</arm_group_label>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals aged 18 years or older presenting to the Emergency Department with acute
             overt UGIB, defined as bloody emesis and/or coffee ground vomiting and/or melena
             within the previous 48 hours.

        Exclusion Criteria:

          -  Stable for discharge without further testing (Glasgow Blatchford Score of 0

          -  Upper GI bleed with hemodynamic shock (BP &lt;90mmHg and pulse &gt; 120 beats per minute)

          -  Active hematemesis

          -  High- Risk Upper GI Bleed (Glasgow Blatchford Score greater than or equal to 6)

          -  Known history of gastric cancer

          -  Known history of gastric or esophageal varices

          -  GI surgery within the last 6 months

          -  Dysphagia, swallowing disorder, Zencker' s diverticulum, suspected bowel obstruction
             or perforation.

          -  Gastroparesis, Gastric outlet obstruction, Crohn's disease, past UGI tract surgery

          -  Pregnancy/ lactation

          -  Altered mental status (e.g., hepatic encephalopathy) that limits the ability to
             swallow a capsule

          -  Expected to have Magnetic Resonance Imaging examination within 7 days

          -  On medications that may coat the upper GI tract such as antacids or sucralfate or
             Maalox.

          -  Patient either refuses or is unable to get traditional EGD.

          -  Patient does not have reliable contact information - no phone, no permanent address.

          -  Patient refuses

          -  Unable to provide written consent

          -  Prisoner

          -  Non-English Speaker

          -  Suspected small bowel or lower GI Bleeding

          -  Unable to follow up with confirmatory EGD.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Meltzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>George Washington University- Department of Emergency Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Meltzer, MD</last_name>
    <phone>202-741-2952</phone>
    <email>ameltzer@mfa.gwu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maxine Le Saux, BS</last_name>
    <phone>202-741-2917</phone>
    <email>mlesaux@mfa.gwu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Meltzer, MD</last_name>
      <phone>202-741-2952</phone>
      <email>ameltzer@mfa.gwu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Maxine Le Saux, BS</last_name>
      <phone>202-741-2917</phone>
      <email>mlesaux@mfa.gwu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Meltzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gregory Fermann, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gregory Fermann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dan delPortal, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dan delPortal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nina Gentile, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Andrew Meltzer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

